[{"NetIncomeLoss_1_Q1_USD":69700000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":38000000.0,"BilledContractReceivables_0_Q1_USD":134000000.0,"InterestPaidNet_1_Q1_USD":12400000.0,"OperatingCostsAndExpenses_1_Q1_USD":247600000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-24400000.0,"IncomeTaxesPaid_1_Q1_USD":1500000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":6600000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-56100000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":50600000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-200000.0,"AssetsCurrent_0_Q1_USD":1181100000.0,"OperatingLeaseExpense_1_Q1_USD":400000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1200000.0,"LongTermDebt_0_Q1_USD":869200000.0,"LongTermDebtCurrent_0_Q1_USD":26000000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-3500000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":80900000.0,"ContractWithCustomerLiability_0_Q1_USD":112800000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":99300000.0,"TreasuryStockShares_0_Q1_shares":1200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":100000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":5200000.0,"TreasuryStockValue_0_Q1_USD":39600000.0,"CommonStockSharesIssued_0_Q1_shares":54800000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":163100000.0,"Assets_0_Q1_USD":2900100000.0,"ShareBasedCompensation_1_Q1_USD":10500000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":29700000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":1300000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":49100000.0,"RestrictedCashCurrent_0_Q1_USD":200000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":25000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":183900000.0,"EarningsPerShareBasic_1_Q1_USD":1.31,"RepaymentsOfConvertibleDebt_1_Q1_USD":10600000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":54500000.0,"AssetsFairValueDisclosure_0_Q1_USD":450100000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-40000000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-1700000.0,"AccountsReceivableNetCurrent_0_Q1_USD":184400000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":15500000.0,"CommonStockValue_0_Q1_USD":100000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":28700000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":1700000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.26,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-22200000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":700000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":1100000.0,"IncreaseDecreaseInInventories_1_Q1_USD":99900000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":70600000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":20100000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":14900000.0,"OtherAssetsNoncurrent_0_Q1_USD":111400000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":547800000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":26300000.0,"Liabilities_0_Q1_USD":1377300000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":6900000.0,"OperatingLeaseLiability_0_Q1_USD":31600000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-29400000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":10000000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":343000000.0,"EarningsPerShareDiluted_1_Q1_USD":1.28,"AmortizationOfFinancingCosts_1_Q1_USD":1000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":271500000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":900000.0,"OperatingLeaseLeaseIncome_1_Q1_USD":18700000.0,"Goodwill_0_Q1_USD":266500000.0,"InventoryRawMaterialsAndSuppliesNetOfReserves_0_Q1_USD":194300000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":12200000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-2200000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":5100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":53300000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":32700000.0,"LiabilitiesCurrent_0_Q1_USD":370200000.0,"RepaymentsOfMediumTermNotes_1_Q1_USD":5600000.0,"CommonStockSharesOutstanding_0_Q1_shares":53600000.0,"AccountsPayableCurrent_0_Q1_USD":142200000.0,"InterestExpense_1_Q1_USD":8500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":548000000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":42200000.0,"LongTermDebtNoncurrent_0_Q1_USD":833100000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":648200000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.041,"AdditionalPaidInCapital_0_Q1_USD":790100000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":648200000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":53300000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":32500000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":5300000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":692900000.0,"NonoperatingIncomeExpense_1_Q1_USD":-10200000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":52500000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-42100000.0,"LeaseCost_1_Q1_USD":1700000.0,"OperatingIncomeLoss_1_Q1_USD":95400000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":85200000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":3100000.0,"NotesPayableCurrent_0_Q1_USD":26000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":3100000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_1_Q1_USD":-500000.0,"InventoryNet_0_Q1_USD":406500000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":38000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1_Q1_USD":21200000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":60300000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":832100000.0,"PreferredStockValue_0_Q1_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-1700000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_1_Q1_USD":-1400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-73500000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2900100000.0,"PreferredStockSharesAuthorized_0_Q1_shares":15000000.0,"DerivativeLiabilities_0_Q1_USD":12600000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":10500000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":964400000.0,"DeferredFinanceCostsNoncurrentNet_0_Q1_USD":10100000.0,"UnbilledContractsReceivable_0_Q1_USD":50400000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5300000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":62900000.0,"OtherLiabilitiesCurrent_0_Q1_USD":122000000.0,"StockholdersEquity_0_Q1_USD":1522800000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":52500000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":56100000.0,"DeferredCostsCurrent_0_Q1_USD":41300000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":796600000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":55000000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":9400000.0,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210430"}]